Healthcare
Live Price
Offline$0.0009
-10.00% today
1Y Change
+11.11%
Window
Jun 23, 2025 → Jun 15, 2026
Coverage: 247 bars · Jun 23, 2025 → Jun 15, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Pharmagreen Biotech Inc. (PHBI) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 11.1% across the available one-year price window (Jun 23, 2025 → Jun 15, 2026). Baseline metrics include revenue growth of +13.7%, EPS growth of -25.0%, a dividend yield of 0.0%. What stands out right now is revenue +13.7%, EPS -25.0%, free cash flow +62.0% with operating margin -37.5% and ROIC 14.1%. Valuation is more restrained than many high-expectation growth names at price/sales 0.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines PHBI price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PHBI
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PHBI Max Drawdown
-80.00%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PHBI and SPY.
Unable to load analyst forecasts.
Timed out loading forecasts for PHBI
Next Step
Forecasts are most valuable when they sit beside comparisons, earnings setup, and the rest of the business story.